ASXL1 and myelodysplastic syndrome: Clonal haematopoiesis of indeterminate potential (CHIP), linked to DNMT3A, TET2, and ASXL1 mutations, is a recently described phenomenon preceding MDS that has been associated with cardiovascular diseases [6, 7].